Inventor · disambiguated record
Andrew M. Wollacott
Also filed as: WOLLACOTT ANDREW · WOLLACOTT ANDREW M
42 granted patents·19 pending applications·133 citations·filing 2008–2025
97Inventor score
Top patents by PatentIndex Score
61 records- 0197US11136385B2Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody moleculeVISTERRA INC·Filed 2020·Granted Oct 5, 2021·4 cites·38 claims
- 0297US10954296B2Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGAVISTERRA INC·Filed 2020·Granted Mar 23, 2021·4 cites·51 claims
- 0397US10485238B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2018·Granted Nov 26, 2019·14 cites·19 claims
- 0497US9713334B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2016·Granted Jul 25, 2017·19 cites·11 claims
- 0596US10968270B2Antibody molecules to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2020·Granted Apr 6, 2021·3 cites·30 claims
- 0696US9322033B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2013·Granted Apr 26, 2016·19 cites·22 claims
- 0794US12054522B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2022·Granted Aug 6, 2024·1 cites·22 claims
- 0894US11981709B2Proteins toxic to Hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2022·Granted May 14, 2024·1 cites·22 claims
- 0994US10689666B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2019·Granted Jun 23, 2020·2 cites·28 claims
- 1093US10385123B2Antibody molecules to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2018·Granted Aug 20, 2019·8 cites·30 claims
- 1193US9238678B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsBOWEN DAVID J·Filed 2012·Granted Jan 19, 2016·13 cites·24 claims
- 1292US10023874B2Herbicide tolerance genes and methods of use thereofMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Jul 17, 2018·6 cites·98 claims
- 1392US9777289B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Oct 3, 2017·4 cites·22 claims
- 1491US12319716B2Proteins toxic to Hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2024·Granted Jun 3, 2025·0 cites·22 claims
- 1591US2025066464A1Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (april)VISTERRA INC·Filed 2024·Application pending·0 cites
- 1690US11242540B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2020·Granted Feb 8, 2022·2 cites·20 claims
- 1790US10669556B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2019·Granted Jun 2, 2020·2 cites·27 claims
- 1889US11912781B2Humanized complement 5A receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2022·Granted Feb 27, 2024·1 cites·10 claims
- 1989US10316331B2Insect inhibitory toxin family active against Hemipteran and/or Lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Jun 11, 2019·2 cites·28 claims
- 2089US8340951B2Synthetic enzymes derived from computational designBAKER DAVID·Filed 2008·Granted Dec 25, 2012·13 cites·25 claims
- 2189US2024247281A1Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2024·Application pending·0 cites
- 2288US10513553B2Compositions and methods for treating and preventing influenzaVISTERRA INC·Filed 2016·Granted Dec 24, 2019·6 cites·22 claims
- 2387US10981982B2Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2020·Granted Apr 20, 2021·1 cites·48 claims
- 2486US12264203B2Humanized complement 5a receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2024·Granted Apr 1, 2025·0 cites·13 claims
- 2586US12049636B2Herbicide tolerance genes and methods of use thereofMONSANTO TECHNOLOGY LLC·Filed 2023·Granted Jul 30, 2024·0 cites·23 claims
- 2686US10897910B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2019·Granted Jan 26, 2021·1 cites·22 claims
- 2786US2025320260A1Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2025·Application pending·0 cites
- 2884US12227587B2Humanized complement 5A receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2024·Granted Feb 18, 2025·0 cites·10 claims
- 2984US10188115B2Proteins toxic to Hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2017·Granted Jan 29, 2019·1 cites·22 claims
- 3083US12415865B2Antibody molecules to C5AR1 and uses thereofVISTERRA INC·Filed 2023·Granted Sep 16, 2025·0 cites·2 claims
- 3183US12187807B2Antibody molecules to C5AR1 and uses thereofVISTERRA INC·Filed 2023·Granted Jan 7, 2025·0 cites·4 claims
- 3283US11168131B2Antibody molecule-drug conjugates and uses thereofVISTERRA INC·Filed 2016·Granted Nov 9, 2021·4 cites·15 claims
- 3382US11913010B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2022·Granted Feb 27, 2024·0 cites·16 claims
- 3480US12091451B2Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)VISTERRA INC·Filed 2021·Granted Sep 17, 2024·0 cites·18 claims
- 3579US9957524B2Pesticidal toxin proteins active against coleopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2015·Granted May 1, 2018·2 cites·4 claims
- 3678US11459359B2Proteins toxic to hemipteran insect speciesMONSANTO TECHNOLOGY LLC·Filed 2020·Granted Oct 4, 2022·0 cites·22 claims
- 3776US2025296982A1Engineered polypeptides and uses thereofVISTERRA INC·Filed 2025·Application pending·0 cites
- 3874US2025043014A1Antibody molecules to april and uses thereofVISTERRA INC·Filed 2024·Application pending·0 cites
- 3973US11655480B2Herbicide tolerance genes and methods of use thereofMONSANTO TECHNOLOGY LLC·Filed 2021·Granted May 23, 2023·0 cites·23 claims
- 4071US11773179B2Antibody molecules to C5aR1 and uses thereofVISTERRA INC·Filed 2021·Granted Oct 3, 2023·0 cites·4 claims
- 4171US2025171555A1Humanized complement 5a receptor 1 antibodies and methods of use thereofVISTERRA INC·Filed 2025·Application pending·0 cites
- 4271US2024342300A1Antibody molecule-drug conjugates and uses thereofVISTERRA INC·Filed 2024·Application pending·0 cites
- 4370US2024092921A1Antibody molecules to april and uses thereofVISTERRA INC·Filed 2023·Application pending·0 cites
- 4470US2019330326A1Antibody molecules to a proliferation-inducing ligand (april)VISTERRA INC·Filed 2019·Application pending·0 cites
- 4569US10900050B2Herbicide tolerance genes and methods of use thereofMONSANTO TECHNOLOGY LLC·Filed 2018·Granted Jan 26, 2021·0 cites·20 claims
- 4667US2025382379A1Humanized antibody molecules to cd138 and uses thereofVISTERRA INC·Filed 2025·Application pending·0 cites
- 4765US9732355B2Insect inhibitory toxin family active against hemipteran and/or lepidopteran insectsMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Aug 15, 2017·0 cites·24 claims
- 4864US12338291B2Humanized antibody molecules to CD138 and uses thereofVISTERRA INC·Filed 2020·Granted Jun 24, 2025·0 cites·21 claims
- 4964US2022267418A1Antibody molecule-drug conjugates and uses thereofVISTERRA INC·Filed 2021·Application pending·0 cites
- 5063US2017145086A1Antibody molecules to april and uses thereofVISTERRA INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →